Emerging World Pharma Inc. President Provides Update From Global
Pharma Corp. Annual Meeting
SUNYANI, GHANA -- (Marketwire) -- 10/26/12 -- Emerging World Pharma
Inc. (PINKSHEETS: EWPI) -- Emerging World Pharma president Steve
Ignatavicius was in attendance at the annual meeting of the board of
directors from the company's strategic partner African Global Pharma
Corp. The primary focus of the meeting was the restructuring and
consolidation of operations at African Global Pharma Corp. GH.
The board of directors ratified the appointment of African Global
Pharma GH president ROY ANTHONY DUODU-SARPONG. Mr. Roy Duodu-Sarpong
will oversee all operations in the company's facility in Ghana. Mr.
Duodo-Sarpong is a Business Executive with management skills in the
Information Technology and Financial Institutions business sector. He
previously worked in consulting and management positions at US West
Communications through AIC, Ontario Hydro, Bank of Montreal, Royal
Bank of Canada and Nortel Networks. Roy is a professional who
believes that industries and people must be receptive to change when
the world turns. He possesses a natural ability for negotiation and
gentle persuasion, making him a perfect candidate to deal with
contracts and manage a turn-key project. He holds an MBA Degree from
the Centre of Graduate Management School at Keele.
The directors also agreed to put on hiatus the project in Estonia
until final review. Moving forward, African Global Pharma Corp.
intends to introduce a line of over-the-counter pharmaceuticals it
will be making available beginning November 1, 2012.
About African Global Pharma, Ghana
African Global Pharma (Ghana)
Limited is an affiliated company of African Global Pharma Corp. of
Canada with business partnership with the Catholic Diocese of Sunyani
to distribute all our manufactured drugs to the Catholic Mission
Hospitals. African Global Pharma's production facility in Sunyani,
Ghana was fully rehabilitated and built by African Global Pharma
Corp, Canada. The plant and its operations are headquartered in
Sunyani at the Diocesan Bldg.
For more on AGP, click here
About Emerging World Pharma Inc.
Emerging World Pharma Inc. is an
investor in generic based pharmaceutical compani
within developing nations.
The company focuses its investments on generic pharmaceutical
companies that have contracts with three major buyer groups; church,
government and wholesalers. Market research shows that these branches
are the most secure, protected and reputable for the distribution of
For more on Emerging World Pharma Inc., click here
This press release contains "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995.
Statements in this release that are forward-looking statements are
based on current expectations and assumptions that are subject to
known and unknown risks, uncertainties, or other factors which may
cause actual results, performance, or achievements of the company to
be materially different from any future results, performance, or
achievements expressed or implied by such forward-looking statements.
Actual results could differ materially because of factors such as the
effect of general economic and market conditions, entry into markets
with vigorous competition, market acceptance of new products and
services, continued acceptance of existing products and services,
technological shifts, and delays in product development and related
product release schedules, any of which may cause revenues and income
to fall short of anticipated levels. All information in this release
is as of the date of this release. The company undertakes no duty to
update any forward-looking statement to conform the statement to
actual results or changes in the company's expectations.
Emerging World Pharma Inc.
Investor Relations Division
Press spacebar to pause and continue. Press esc to stop.